Correlation Between Aerovate Therapeutics and Wilmar International

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Wilmar International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Wilmar International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Wilmar International, you can compare the effects of market volatilities on Aerovate Therapeutics and Wilmar International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Wilmar International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Wilmar International.

Diversification Opportunities for Aerovate Therapeutics and Wilmar International

-0.44

Correlation Coefficient

Aerovate Therapeutics  Wilmar International

Very good diversification

The 3 months correlation between Aerovate and Wilmar is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Wilmar International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wilmar International and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Wilmar International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wilmar International has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Wilmar International go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Wilmar International

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Wilmar International. In addition to that, Aerovate Therapeutics is 1.22 times more volatile than Wilmar International. It trades about -0.04 of its total potential returns per unit of risk. Wilmar International is currently generating about 0.1 per unit of volatility. If you would invest  2,284  in Wilmar International on December 29, 2024 and sell it today you would earn a total of  194.00  from holding Wilmar International or generate 8.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Wilmar International

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Wilmar International

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Wilmar International are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile forward indicators, Wilmar International may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Aerovate Therapeutics and Wilmar International

The main advantage of trading using opposite Aerovate Therapeutics and Wilmar International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Wilmar International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wilmar International will offset losses from the drop in Wilmar International's long position.

The idea behind Aerovate Therapeutics and Wilmar International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.